Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Innovative drug delivery methods for combating antimicrobial resistance

View through CrossRef
 Antimicrobial resistance (AMR) poses a significant threat to global health, complicating the treatment of infectious diseases and leading to increased morbidity and mortality. Innovative drug delivery methods are emerging as critical strategies to combat AMR by enhancing the efficacy of existing antibiotics and facilitating the development of new therapeutic approaches. This paper explores the role of novel drug delivery systems in addressing AMR challenges. One of the primary approaches is the development of targeted drug delivery systems that improve the precision of antibiotic therapy. Nanotechnology has revolutionized this field, enabling the creation of nanoparticles and nanocarriers that can deliver drugs directly to infection sites, reducing systemic side effects and enhancing drug concentration at the target. These advanced delivery systems can be engineered to release antibiotics in a controlled manner, overcoming bacterial resistance mechanisms and minimizing the likelihood of resistance development. Another promising strategy involves the use of combination therapies delivered through innovative methods. By combining antibiotics with adjuvants or resistance-modifying agents, these systems can counteract resistance mechanisms and restore the effectiveness of existing drugs. For instance, drug delivery platforms that co-deliver antibiotics with inhibitors of bacterial efflux pumps or biofilm formation can enhance the treatment of resistant infections. The integration of smart drug delivery systems, which respond to environmental stimuli such as pH changes or specific bacterial enzymes, offers additional advantages. These systems can release antibiotics only in the presence of resistant bacteria, thereby reducing the overall exposure of bacteria to antibiotics and decreasing the risk of resistance. Innovative drug delivery methods also include the development of long-acting formulations and implants that provide sustained release of antibiotics over extended periods. Such systems reduce the frequency of dosing, improve patient adherence, and ensure consistent therapeutic levels, which are crucial for managing chronic infections and preventing resistance. In conclusion, innovative drug delivery methods are pivotal in the fight against AMR. By enhancing drug targeting, combining therapies, and utilizing smart and sustained-release systems, these approaches offer promising solutions to improve antibiotic efficacy and curb resistance. Continued research and development in this area are essential for advancing therapeutic strategies and ensuring effective management of infectious diseases in the face of rising antimicrobial resistance. Keywords:  Innovative, Drug Delivery Methods, Combating, Antimicrobial, Resistance.
Title: Innovative drug delivery methods for combating antimicrobial resistance
Description:
 Antimicrobial resistance (AMR) poses a significant threat to global health, complicating the treatment of infectious diseases and leading to increased morbidity and mortality.
Innovative drug delivery methods are emerging as critical strategies to combat AMR by enhancing the efficacy of existing antibiotics and facilitating the development of new therapeutic approaches.
This paper explores the role of novel drug delivery systems in addressing AMR challenges.
One of the primary approaches is the development of targeted drug delivery systems that improve the precision of antibiotic therapy.
Nanotechnology has revolutionized this field, enabling the creation of nanoparticles and nanocarriers that can deliver drugs directly to infection sites, reducing systemic side effects and enhancing drug concentration at the target.
These advanced delivery systems can be engineered to release antibiotics in a controlled manner, overcoming bacterial resistance mechanisms and minimizing the likelihood of resistance development.
Another promising strategy involves the use of combination therapies delivered through innovative methods.
By combining antibiotics with adjuvants or resistance-modifying agents, these systems can counteract resistance mechanisms and restore the effectiveness of existing drugs.
For instance, drug delivery platforms that co-deliver antibiotics with inhibitors of bacterial efflux pumps or biofilm formation can enhance the treatment of resistant infections.
The integration of smart drug delivery systems, which respond to environmental stimuli such as pH changes or specific bacterial enzymes, offers additional advantages.
These systems can release antibiotics only in the presence of resistant bacteria, thereby reducing the overall exposure of bacteria to antibiotics and decreasing the risk of resistance.
Innovative drug delivery methods also include the development of long-acting formulations and implants that provide sustained release of antibiotics over extended periods.
Such systems reduce the frequency of dosing, improve patient adherence, and ensure consistent therapeutic levels, which are crucial for managing chronic infections and preventing resistance.
In conclusion, innovative drug delivery methods are pivotal in the fight against AMR.
By enhancing drug targeting, combining therapies, and utilizing smart and sustained-release systems, these approaches offer promising solutions to improve antibiotic efficacy and curb resistance.
Continued research and development in this area are essential for advancing therapeutic strategies and ensuring effective management of infectious diseases in the face of rising antimicrobial resistance.
Keywords:  Innovative, Drug Delivery Methods, Combating, Antimicrobial, Resistance.

Related Results

Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
BACKGROUND Globally antimicrobial resistance is rising, and the Indian scenario is also similar to antimicrobial awareness. The study literature on awareness regarding antimi...
The Promise of Exosomes as Drug Delivery Systems
The Promise of Exosomes as Drug Delivery Systems
Exosomes are small extracellular vesicles that play a role in cell-to-cell communication by transferring bioactive molecules such as proteins, nucleic acids, and lipids between cel...
Controlled Drug Delivery Systems
Controlled Drug Delivery Systems
In most forms of drug delivery, spatial localization and duration of drug concentration are constrained by organ physiology and metabolism. For example, drugs administered orally w...
Antimicrobial Use and Resistance in Brazil: An Overview of Regulatory Measures, Consumption Patterns, and Stewardship Challenges
Antimicrobial Use and Resistance in Brazil: An Overview of Regulatory Measures, Consumption Patterns, and Stewardship Challenges
Antimicrobial resistance is one of the most important global public health challenges, particularly in low and middle-income countries where antimicrobial consumption remains high....
Advanced Strategy and Future Perspectives in Drug Delivery System
Advanced Strategy and Future Perspectives in Drug Delivery System
One of the main issues with the drug delivery system is delivering the drug to specific target site with anticipated concentration to produce a desired therapeutic potential of the...

Back to Top